BioMark’s Quebec Laboratory Begins To Take Shape
BioMark Diagnostics is pleased to announce that the installation of its Quebec laboratory is now underway. With the installation of the Sciex QTrap 6500+ high performance mass spectrometer, BioMark is on target with its plan to build an optimal laboratory infrastructure that will serve as the gold-standard for world-class cancer detection and research. Dr. Jeff […]
Biomark to Expand Treatment Response Trial to Advanced Lung Cancer Patient Receiving Immunotherapy
Vancouver, British Columbia – (June 29th, 2021) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) is pleased to announce that Health Canada has approved its clinical trial application (CTA) and has granted a Letter of No Objection (NOL) for its application entitled Excretion of Acetylamantadine (AA) by Lung Cancer Patients During a […]
